SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter Riedell, Kenneth R Carson, A drug safety evaluation of rituximab and risk of hepatitis B, Expert Opinion on Drug Safety, 2014, 13, 7, 977

    CrossRef

  2. 2
    Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao, Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management, Hepatology International, 2013, 7, 2, 316

    CrossRef

  3. 3
    Amanda Abramson, Alan Menter, Robert Perrillo, Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management, Journal of the American Academy of Dermatology, 2012, 67, 6, 1349

    CrossRef

  4. 4
    D. H. T. Mya, S. T. Han, Y. C. Linn, W. Y. K. Hwang, Y. T. Goh, D. C. L. Tan, Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection, Annals of Oncology, 2012, 23, 2, 421

    CrossRef

  5. 5
    Ramazan Idilman, Mutlu Arat, Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation, Expert Review of Anti-infective Therapy, 2011, 9, 8, 641

    CrossRef

  6. 6
    W. Miehsler, G. Novacek, H. Wenzl, H. Vogelsang, P. Knoflach, A. Kaser, C. Dejaco, W. Petritsch, M. Kapitan, H. Maier, W. Graninger, H. Tilg, W. Reinisch, A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease, Journal of Crohn's and Colitis, 2010, 4, 3, 221

    CrossRef

  7. 7
    Kavitha Gopal, Albert D. Min, Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant, Current Hepatitis Reports, 2010, 9, 3, 178

    CrossRef

  8. You have free access to this content8
    John S Lubel, Peter W Angus, Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management, Journal of Gastroenterology and Hepatology, 2010, 25, 5
  9. 9
    Münci Yağcı, Zübeyde Nur Özkurt, Zeynep Arzu Yeğin, Zeynep Akı, Gülsan Türköz Sucak, Rauf Haznedar, Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies, Hematology, 2010, 15, 4, 240

    CrossRef

  10. 10
    L. REJTO, A. SCHLAMMADINGER, P. ILONCZAI, I. TORNAI, P. BATAR, GY. REMENYI, A. KISS, M. UDVARDY, Treatment of mantle cell lymphoma with autologous stem-cell transplantation in a patient with severe congenital haemophilia-A and chronic (B and C virus) hepatitis, Haemophilia, 2010, 16, 4
  11. 11
    Umut Kalyoncu, Ozlem Yonem, Meral Calguneri, Osman Ersoy, Omer Karadag, Ali Akdogan, Sule A Bilgen, Sedat Kiraz, Ihsan Ertenli, Yusuf Bayraktar, Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders, Rheumatology International, 2009, 29, 7, 777

    CrossRef

  12. 12
    Anthony Post, Shweta Nagendra, Reactivation of hepatitis B: Pathogenesis and clinical implications, Current Infectious Disease Reports, 2009, 11, 2, 113

    CrossRef

  13. 13
    C-C. Wang, S-Y. Wang, T-H. Tsai, Chronic hepatitis B reactivation and systemic glucocorticosteroid therapy, British Journal of Dermatology, 2008, 158, 6
  14. 14
    Ali Amouri, Lassaad Chtourou, Leila Mnif, Nabi Tahri, Prise en charge de la réactivation virale B au cours d’un traitement chimiothérapique ou immunosuppresseur, La Presse Médicale, 2008, 37, 11, 1591

    CrossRef

  15. 15
    Amir Shlomai, Yosef Shaul, The “metabolovirus” model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon, Medical Hypotheses, 2008, 71, 1, 53

    CrossRef

  16. 16
    Holbrook E. Kohrt, Daniel L. Ouyang, Emmet B. Keeffe, Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection, Clinics in Liver Disease, 2007, 11, 4, 965

    CrossRef

  17. 17
    H. Dussauze, I. Bourgault, L.-M. Doleris, J. Prinseau, A. Baglin, T. Hanslik, Corticothérapie systémique et risque infectieux, La Revue de Médecine Interne, 2007, 28, 12, 841

    CrossRef

  18. 18
    Anne Thirot-Bidault, Jaata Ben Mansour, Olivier Lambotte, Caroline Besson, Rita Bou-Farah, Coralie Pallier, Catherine Buffet, Évolution fatale après réactivation d’une hépatite chronique virale B occulte dans les suites d’une chimiothérapie pour lymphome chez un malade porteur de l’anticorps anti-HBc isolé, Gastroentérologie Clinique et Biologique, 2007, 31, 11, 1028

    CrossRef

  19. 19
    J. S. Lubel, A. G. Testro, P. W. Angus, Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management, Internal Medicine Journal, 2007, 37, 10
  20. 20
    Yasser Khaled, Amr Hanbali, Hepatitis B virus reactivation in a case of Waldenstrom's macroglobulinemia treated with chemotherapy and Rituximab despite Adefovir prophylaxis, American Journal of Hematology, 2007, 82, 7
  21. 21
    Surakit Pungpapong, W. Ray Kim, John J. Poterucha, Natural History of Hepatitis B Virus Infection: An Update for Clinicians, Mayo Clinic Proceedings, 2007, 82, 8, 967

    CrossRef

  22. 22
    Gadi Lalazar, Deborah Rund, Daniel Shouval, Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies, British Journal of Haematology, 2007, 136, 5
  23. 23
    Soon-Thye Lim, Gao Fei, Richard Quek, Lay-Cheng Lim, Lai-Heng Lee, Swee-Peng Yap, Susan Loong, Miriam Tao, The relationship of hepatitis B virus infection and non-Hodgkin’s lymphoma and its impact on clinical characteristics and prognosis, European Journal of Haematology, 2007, 79, 2
  24. 24
    H. E. KOHRT, D. L. OUYANG, E. B. KEEFFE, Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection, Alimentary Pharmacology & Therapeutics, 2006, 24, 7